Episode check · Lifestyle and genes
Bioidentical hormone therapy does not cause breast cancer, the episode says. Four studies conflict on it.
We checked six claims from a 37-minute episode on breast cancer risk against 72 studies. Four studies conflict on the lead, that bioidentical hormone therapy, estradiol with micronized progesterone, does not raise breast cancer risk. Two French studies found no rise. A pooled analysis of 58 studies found the risk about doubled. Few studies test this form of therapy at all. Three claims have strong support. More body fat means more estrogen, in women and in men. Exercise lowers the risk of getting breast cancer. And risk rises even at low amounts of alcohol. The studies lean toward high insulin raising risk, exercise lowering recurrence, and hormone therapy feeding a cancer that is already there. They also lean toward low butyrate raising risk, though most of those studies counted gut bacteria, not butyrate itself. The chapters we did not check are in grey.
“It's Not Bad Luck. This Is What Actually Makes Your Body Vulnerable to Breast Cancer”
12 chapters · 6 claims checked against 72 studies · 7 chapters not checked yet · checked Oct 27, 2026 Watch on YouTube →
0:00 “And I think the reason we're seeing all of these increases in cancer in younger people is twofold. One is our microbiome and toxins.” Said on tape, not checked yet.
4:36 “We can't unfortunately prevent all cancer, but there's so much we can do every day that influences whether cancer grows or doesn't grow.” Said on tape, not checked yet.
The Terrain Theory of Health and Cancer Susceptibility
“We know that high levels of insulin in the body really create growth of cancer cells. So, we're always evaluating, does this person have high levels of insulin? Do they have insulin resistance?”
Elizabeth Boham, a guest on this episode.
What 9 studies found
5 agree · 3 partly agree · 1 disagree
Five of nine studies agree. In the Women's Health Initiative, women past menopause with high insulin had a higher risk of breast cancer, even after body weight was counted. A genetic study found risk rose about 70% for each step up in fasting insulin. One disagrees: in mostly younger women, high insulin was not a real risk factor. Three are mixed. A pooled analysis of 22 studies found no link with fasting insulin, though C-peptide, a marker of how much insulin the body makes, was linked.
Computed from 9 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words“We know that high levels of insulin in the body really create growth of cancer cells.”
What 6 studies found
3 agree · 3 partly agree
Three of six studies agree. In 604 women with breast cancer, each 1 ng/mL rise in C-peptide went with a 35% higher risk of dying of breast cancer. In Rome, an insulin level above 13 went with more than twice the risk of the cancer progressing. Three are mixed: in some, the link depended on the type of tumour, or was too uncertain to count.
Computed from 6 studies that test this point, each judged by two readers, in full. 5 more studies are waiting for a full read and do not count yet.
Every study and its exact words9:25 “We also know that when there's a lot of toxins that we're being exposed to, that that actually shifts the way that our immune system functions.” Said on tape, not checked yet.
Estrogen Dominance and Environmental Xenoestrogens
“So, we know that when our percentage of body fat is higher, we we actually produce more estrogen. And that's true for men and women.”
Elizabeth Boham, a guest on this episode.
What 5 studies found
5 agree
All five studies agree. Pooled data from 13 studies of women past menopause found estradiol, the main estrogen, was 47% higher in obese women than in thin women, and free estradiol 89% higher. In trials, women who lost weight or body fat lowered their estrogen.
Computed from 5 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words“And that's true for men and women.”
What 7 studies found
5 agree · 2 partly agree
Five of seven studies agree. In 64 very obese men, weight-loss surgery lowered estradiol. A review of men from 30 countries linked overweight to high estradiol, and a genetic study found higher BMI raised it. Two are mixed. In a Danish weight-loss program, estradiol did not fall as men lost weight.
Computed from 7 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsNavigating Menopause and Bioidentical Hormone Replacement Therapy Lead finding
“We don't necessarily think that that bioidentical hormone therapy is causing cancer, right? But we do know that it can cause cancer to grow um if there is cancer cells there.”
Elizabeth Boham, a guest on this episode.
What 4 studies found
2 agree · 1 partly agree · 1 disagree
Few studies test this form of hormone therapy: estradiol, the body's own estrogen, with micronized progesterone. Two of four agree. In 80,377 French women, estrogen with progesterone showed no rise in breast cancer. One disagrees: a pooled analysis of 58 studies found risk about doubled with micronized progesterone too. One is mixed: risk crept up with longer use for some tumour types.
Computed from 4 studies that test this point, each judged by two readers, in full. Sources land on both sides. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words“But we do know that it can cause cancer to grow um if there is cancer cells there.”
What 3 studies found
2 agree · 1 partly agree
Two of three studies agree. Pooled from two trials of hormone therapy after breast cancer, the cancer came back 3.41 times as often. In another trial, tibolone, a hormone-like drug, raised the chance of the cancer coming back. One is mixed: in Danish women, vaginal estrogen raised recurrence only in women taking aromatase inhibitors.
Computed from 3 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsCloser look
French women taking estrogen with progesterone
“Estrogen-progesterone was associated with a relative risk of 1.00 (0.83–1.22), and estrogen–dydrogesterone with a relative risk of 1.16 (0.94–1.43).”
Breast Cancer Res Treat, 2008 · other primary study · PMID 17333341
French women taking estrogen with micronized progesterone
“We found no indication of an increased risk of breast cancer in EP therapy users of micronized progesterone, a result in line with the finding of the E3N cohort [ 19 , 21 ].”
PLoS One, 2013 · other primary study · PMID 24223752
Women in 58 studies, taking many kinds of hormone therapy
“In general, the RR did not differ substantially by the progestagenic constituent of the combinations, including rarely used hormones, such as micronised [natural] progesterone (RR 2·05, 1·38–3·56), although the RR appeared to be somewhat lower for oestrogen plus dydrogesterone ( appendix p 45 ).”
Lancet, 2019 · pooled analysis · PMID 31474332
21:00 “I will look at things like B vitamin status because we need to be able to methylate with sufficient B vitamins to get rid of uh used up estrogen or other toxins, right?” Said on tape, not checked yet.
24:46 “we're seeing, as you mentioned, more breast cancer at a younger age. We're seeing a lot of other cancers as well.” Said on tape, not checked yet.
Microbiome, Toxins, and Breast Cancer Risk
“So when women have a low level of butyrate, they actually have an increased risk of breast cancer.”
Elizabeth Boham, a guest on this episode.
What 9 studies found
1 agree · 7 partly agree · 1 disagree
Butyrate is a fatty acid made by gut bacteria when they break down fiber. Only one of nine studies agrees, and it was small: 12 women with breast cancer had less butyrate in their stool than 12 healthy women. One disagrees: in Malaga, butyrate levels did not differ. Seven are mixed. Most count the gut bacteria that make butyrate, not butyrate itself, and find some of them lower and others higher in women with breast cancer. Every study measured women once, at or after diagnosis, so none can show that low butyrate came first.
Computed from 9 studies that test this point, each judged by two readers, in full. 4 more studies are waiting for a full read and do not count yet.
Every study and its exact wordsCloser look
Seven of nine studies looked at the gut bacteria that make butyrate, or tested women once, at diagnosis. None followed women over time to see whether low butyrate came first.
25:26 “the toxin exposure may have happened when we were a fetus or it may have been an exposure that our mother had that does change our our breast tissue in a way that increases our risk at a later stage in life.” Said on tape, not checked yet.
28:50 “And for our younger women, women with dense breast tissue, it's just not as good of a screening test.” Said on tape, not checked yet.
Practical Lifestyle Interventions for Prevention
“We know that women who exercise daily have less risk of getting breast cancer, but if they do get breast cancer, they have there's less cancer growth for those women or less recurrence.”
Elizabeth Boham, a guest on this episode.
What 10 studies found
9 agree · 1 disagree
Nine of ten studies agree. In pooled cohort studies, the most active women had about 10.3% lower risk than inactive women. Genetic studies, which help rule out other causes, point the same way. One disagrees: in a large study of nurses before menopause, activity made no overall difference. Most studies measured activity over a week, not daily exercise.
Computed from 10 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words“if they do get breast cancer, they have there's less cancer growth for those women or less recurrence.”
What 10 studies found
4 agree · 5 partly agree · 1 disagree
The studies split. Four of ten agree. A pooled analysis of 22 studies found fewer breast cancer events in the most active women after diagnosis. In 1340 women with high-risk breast cancer, those who met activity guidelines had less recurrence. One disagrees: in 1,970 women, activity did not lower recurrence, though it lowered death from any cause. Five are mixed. In 13,302 women from four studies, activity cut death from any cause by 27% but not breast cancer coming back.
Computed from 10 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words“alcohol, you know, for for women, you know, the general recommendation is less is better, right? And we do know, you know, one or two uh drinks a week or even less is probably where we want to focus from a from decreasing risk of breast cancer.”
Elizabeth Boham, a guest on this episode.
What 10 studies found
8 agree · 2 partly agree
Eight of ten studies agree that breast cancer risk rises even at low amounts. In the Nurses' Health Study, risk was higher at 3 to 6 drinks a week. A pooled review found risk rose at half a drink a day or less and found no safe level. Two are mixed. The biggest pooled analysis, of 53 studies, warned that people tend to under-report how much they drink, so it drew no firm conclusion at low amounts.
Computed from 10 studies that test this point, each judged by two readers, in full. 10 more studies are waiting for a full read and do not count yet.
Every study and its exact words34:40 “So, in this book we go through how can you figure out where to focus to create that healthy terrain and decrease your risk of cancer.” Said on tape, not checked yet.
35:25 “I'm so excited to share that my new book is officially available for pre-order today.” Said on tape, not checked yet.
We go through the episode chapter by chapter and pull out each claim. For every claim we can test, two readers read each study in full and mark whether it agrees, partly agrees or disagrees. A fixed rule turns those marks into the badge, the same rule Precis uses on every page. Nobody writes or edits a badge. Chapters we haven't checked are shown in grey, so you can see everything the episode said.
Every quote is 20 seconds or less and opens the episode at that second. This is not medical advice. Talk to your doctor before you change anything.
The Precis Weekly
One email a week with the claims and episodes we checked, what the studies found and the minute each claim was said.
Free. Unsubscribe anytime.